Medical expert of the article

Orthopedist, onco-orthopedist, traumatologist

New publications

Preparations

Muscle and joint pain pills: which ones help and how to choose

Alexey Krivenko, medical reviewer, editor
Last updated: 18.09.2025
Fact-checked
х

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.

We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.

If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.

Musculoskeletal pain is heterogeneous in its causes and mechanisms, so the choice of systemic tablets is always secondary to non-drug measures and topical agents. In acute conditions involving soft tissue damage and osteoarthritis, topical nonsteroidal anti-inflammatory drugs are the first line of treatment, with tablets added when topical forms are insufficient or unavailable. In all cases, the minimum effective dose and short course of treatment apply. [1]

In osteoarthritis in adults, current guidelines recommend caution with systemic analgesics: paracetamol is not prescribed routinely due to its weak analgesia, weak opioids are only allowed occasionally when other options are ineffective, and when prescribing oral nonsteroidal anti-inflammatory drugs, gastrointestinal, cardiovascular, and renal risks must be taken into account. [2]

For acute non-convulsive limb injuries in adults, it is recommended to prioritize topical non-steroidal anti-inflammatory drugs and avoid opioids; if tablets are required, a short course of non-steroidal anti-inflammatory drugs or paracetamol provides a clinically significant effect with a better safety profile. [3]

When pills don't solve the problem: "Red flags"

Urgent care is needed for acute hot, red and swollen joints, high fever or severe systemic symptoms, since until septic arthritis is ruled out, any painkillers will mask the picture and delay proper treatment. [4]

Sudden joint deformity, loss of support, increasing neurological symptoms, significant trauma, rapidly increasing swelling, and, in children, any acute joint swelling associated with fever also require immediate examination. [5]

Table 1. Red flags for which pills are not the solution

Situation Why is it dangerous? What to do
Hot, red, swollen joint, severe pain High risk of septic arthritis Seek immediate medical attention and rule out infection before taking systemic analgesics.
Acute deformation, inability to support Fracture, dislocation, ligament rupture Do not put any load on the limb, urgent visualization
Neurological deficit, weakness, impaired urinary control Compression of nerve structures, cauda equina syndrome Urgent assessment by a specialist
Severe fever, chills Systemic infection or inflammation Urgent diagnostics
The child has acute joint swelling and a fever. Orthopedic emergency See a doctor immediately

Based on current clinical guidelines for hot joint and emergency situations in rheumatology and general practice. [6]

First lines of systemic therapy

Paracetamol. Safe for short-term use at standard doses, but provides limited pain relief for osteoarthritis and a range of musculoskeletal pain conditions, so it is not considered routine monotherapy. The maximum daily dose for a healthy adult is 4,000 mg from all sources, but with long-term use, a safer target is 3,000 mg per day, and for liver disease, 2,000 mg. [7]

Oral nonsteroidal anti-inflammatory drugs. Ibuprofen, naproxen, diclofenac, and selective cyclooxygenase-2 inhibitors are effective for the inflammatory component of pain. Risks include gastrointestinal bleeding, cardiovascular events, and drug-induced deterioration in renal function. Prescribe minimal doses for a short period; in patients at high gastrointestinal risk, add a proton pump inhibitor; and in patients with chronic kidney disease and cardiovascular disease, carefully evaluate the benefit-risk ratio. [8]

Selective cyclooxygenase-2 inhibitors reduce the risk of gastrointestinal complications compared to non-selective drugs, but retain cardiovascular risks. Selective drugs are appropriate for high gastrointestinal risk and low cardiovascular risk, while the minimum dose and short course of treatment remain mandatory. [9]

Table 2. Starting doses and limits for common tablets

Preparation Typical starting doses Maximum per day Key Notes
Paracetamol 500-1000 mg every 6-8 hours 4,000 mg, preferably ≤ 3,000 mg for frequent use In case of liver disease, limit to 2,000 mg; risk of overdose when combined with combination drugs
Ibuprofen 200-400 mg every 6-8 hours 1,200 mg without a prescription; higher doses may be used for short periods if prescribed Consider gastrointestinal, cardiovascular and renal risks
Naproxen 250-500 mg twice daily 1,000 mg May have a more neutral thrombogenic risk profile, but still adhere to the short course principle
Diclofenac 50 mg two to three times a day 150 mg Assess cardiovascular risks, use minimal doses
Celecoxib 100 mg twice daily or 200 mg once daily 400 mg Preferred for high gastrointestinal risk and low cardiovascular risk

Dosages and restrictions are summarized from current safety regulations and clinical guidelines. [10]

Selection of tablets for typical clinical situations

Osteoarthritis of the knee and hip joints. The basis remains education, physical therapy, and weight control. If systemic tablets are necessary, short-term nonsteroidal anti-inflammatory drugs with gastroprotection are chosen in the at-risk group; paracetamol is not used routinely; duloxetine may be added for persistent pain. [11]

Acute soft tissue injury. Initially, topical nonsteroidal anti-inflammatory drugs (NSAIDs) are used. If systemic therapy is required, a short course of oral NSAIDs or paracetamol may help reduce pain and speed return to activity; opioids are not recommended. [12]

Non-specific low back pain. Non-pharmacological treatments are the first choice; if necessary, a short course of non-steroidal anti-inflammatory drugs is acceptable. Skeletal muscle relaxants may reduce pain in the first few days, but they offer little improvement in function and often cause side effects, so their use should be selective and brief. [13]

Chronic widespread pain and fibromyalgia. Systemic nonsteroidal anti-inflammatory drugs are usually ineffective; consider duloxetine or tricyclic antidepressants as part of a multimodal approach, with priority given to non-pharmacological methods. [14]

Table 3. Quick selection by situation

Situation What comes first? When to add tablets What to choose
Osteoarthritis Training, exercise, weight control Pain interferes with activity Nonsteroidal anti-inflammatory drugs (NSAIDs) briefly; if there is a risk of gastrointestinal complications, add a proton pump inhibitor; duloxetine for persistent pain
Acute soft tissue injury Local nonsteroidal anti-inflammatory drugs, rest, gradual loading Not enough effect A short course of oral nonsteroidal anti-inflammatory drugs or paracetamol
Lower back pain Activity, heat treatments, training Short-term pharmacotherapy Nonsteroidal anti-inflammatory drugs; briefly muscle relaxants in selected patients
Fibromyalgia Physical activity, cognitive-behavioral methods In case of severe pain Duloxetine or tricyclic antidepressants, individual selection

Summary table of current recommendations. [15]

Adjuvant drugs: when appropriate

Duloxetine is able to reduce chronic nociceptive and mixed pain in osteoarthritis and chronic low back pain, especially with concomitant depression or hyperalgesia; it is used as an adjunct to basic therapy. [16]

Tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors have evidence of efficacy in a range of chronic pain syndromes, but require assessment of tolerability and risk of drug interactions. [17]

Neuropathic pain medications are appropriate for those with a clear neuropathic component rather than purely nociceptive musculoskeletal pain; refer to specialized guidelines for neuropathic pain. [18]

Table 4. Adjuvant tablets and key notes

Class When to consider Notes
Duloxetine Osteoarthritis with persistent pain, chronic low back pain May reduce pain and improve function, assess tolerance
Amitriptyline and other tricyclics Chronic pain syndromes with sleep disturbances Increase the risk of side effects, titrate the dose
Drugs for neuropathic pain Neuropathic component Follow specialized guides on neuropathic pain

Generalization from modern sources. [19]

Security: Risks and Interactions Often Overlooked

All oral nonsteroidal anti-inflammatory drugs increase the risk of cardiovascular events, possibly within the first few weeks of use; the risk is higher in patients with existing cardiovascular disease. Use minimal doses for short periods and assess your individual risk. [20]

Renal risks are increased with the combination of an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker plus a diuretic plus a nonsteroidal anti-inflammatory drug—a known combination with a high risk of acute kidney injury. Avoid this triple combination, especially during the first weeks of therapy, and monitor creatinine and potassium in susceptible patients. [21]

Ibuprofen may reduce the antithrombotic effect of low-dose aspirin if taken at the wrong time; if concomitant administration is necessary, maintain intervals to maintain the cardioprotection of aspirin.[22]

Selective serotonin reuptake inhibitors and nonsteroidal anti-inflammatory drugs (NSAIDs) together increase the risk of gastrointestinal bleeding; in such patients, the threshold for prescribing a proton pump inhibitor should be low.[23]

Paracetamol is generally safe, but exceeding the total daily dose and combining it with alcohol or chronic liver disease increases the risk of hepatotoxicity; carefully calculate the total dose of all drugs.[24]

Table 5. Dangerous combinations and what to do

Combination What is the risk? How to reduce the risk
Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker + diuretic + nonsteroidal anti-inflammatory drug Acute kidney injury, hyperkalemia Avoid; if necessary, monitor creatinine and potassium, maintain hydration
Nonsteroidal anti-inflammatory drug + selective serotonin reuptake inhibitor Gastrointestinal bleeding Add a proton pump inhibitor, consider an alternative
Ibuprofen with low-dose aspirin without intervals Loss of aspirin cardioprotection Split the doses according to the recommendations.
Nonsteroidal anti-inflammatory drug in a patient with atherosclerosis Cardiovascular events Minimum dose, short course, individual risk assessment
Paracetamol in a high total dose Hepatotoxicity Strictly calculate the total dose, limit in patients with liver diseases

Summarized from regulatory warnings and interaction summaries. [25]

Special groups: where additional precautions are required

Pregnancy. Nonsteroidal anti-inflammatory drugs are contraindicated in the second half of pregnancy due to the risk of oligohydramnios and fetal renal damage; paracetamol remains the drug of choice for short-term use for pain and fever after consultation with a physician. [26]

Chronic kidney disease. Current guidelines recommend avoiding systemic nonsteroidal anti-inflammatory drugs or using them very cautiously and briefly, with monitoring of renal function, as they may worsen progression and cause acute injury. [27]

Cardiovascular disease. Any systemic nonsteroidal anti-inflammatory drug increases the relative risk of cardiovascular events, so the choice is made in favor of the minimum doses for the shortest period after assessing the risk profile. [28]

Liver disease and alcohol consumption. Paracetamol is limited to a daily dose, carefully considering all sources, and in cases of severe liver dysfunction, an individual pain management plan is selected. [29]

Table 6. Special groups and practical guidelines

Situation What to consider Practical solution
Pregnancy Risks of nonsteroidal anti-inflammatory drugs from week 20 Paracetamol is preferred, briefly based on indications
Chronic kidney disease Risk of deterioration of kidney function Avoid nonsteroidal anti-inflammatory drugs or use them for short periods with monitoring
Cardiovascular diseases Increased risk of heart attack and stroke Minimal doses, short courses, evaluation of alternatives
Liver diseases Risk of paracetamol hepatotoxicity Limit daily intake, consider all sources

According to current clinical guidelines and regulatory warnings. [30]

How to take pills correctly

Start with the lowest effective dose and assess the effect at frequent intervals, reducing the frequency as improvement occurs. Avoid concomitant use of two nonsteroidal anti-inflammatory drugs and carefully calculate the total paracetamol dose from all medications. If you have risk factors for gastrointestinal bleeding, protect your stomach with a proton pump inhibitor and avoid combining with alcohol. [31]

If NSAIDs must be used alongside low-dose aspirin, maintain time intervals to avoid compromising aspirin's cardioprotective effects. When prescribing therapy to patients with chronic conditions, monitor the safety profile and avoid high-risk combinations, including a "triple whammy" for kidney damage. [32]

Brief selection algorithm

  1. Eliminate "red flags." 2) Maximize non-pharmacological measures and topical forms. 3) For systemic therapy, start with a short course of non-steroidal anti-inflammatory drugs if there is an inflammatory component, or paracetamol if contraindicated. 4) For chronic, persistent pain, consider duloxetine or tricyclic antidepressants as adjuvants. 5) Always assess risks and interactions, including cardiovascular and renal profile. [33]